US Stock MarketDetailed Quotes

MBRX Moleculin Biotech

Watchlist
  • 4.6400
  • +0.2200+4.98%
Close May 30 16:00 ET
10.73MMarket Cap-358P/E (TTM)

Moleculin Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-11.63%-6.72M
12.80%-24.1M
25.48%-5.41M
0.34%-7.55M
35.93%-5.13M
-25.22%-6.02M
-45.84%-27.64M
-70.41%-7.26M
-76.70%-7.58M
-17.99%-8M
Net income from continuing operations
37.21%-4.97M
-2.56%-29.77M
-51.68%-10.27M
34.86%-5.61M
11.82%-5.98M
-15.26%-7.92M
-82.62%-29.03M
-139.65%-6.77M
-96.60%-8.61M
-59.68%-6.78M
Operating gains losses
-3,630.77%-1.46M
178.20%1.04M
841.72%1.12M
99.76%-1K
94.03%-36K
75.63%-39K
80.16%-1.34M
93.43%-151K
74.91%-421K
48.59%-603K
Depreciation and amortization
6.67%32K
-2.31%127K
9.38%35K
-3.13%31K
-8.82%31K
-6.25%30K
-20.73%130K
-5.88%32K
-23.81%32K
-22.73%34K
Other non cash items
-87.76%108K
868.48%891K
450.00%14K
-91.67%1K
0.00%-6K
880.00%882K
-4.17%92K
33.33%-4K
271.43%12K
-50.00%-6K
Change In working capital
-275.86%-925K
624.11%1.62M
457.91%3.21M
-446.35%-2.47M
129.92%348K
-66.56%526K
-78.42%224K
-417.31%-898K
-5.82%712K
36.69%-1.16M
-Change in prepaid assets
38.17%590K
68.26%-272K
-53.69%301K
-17.12%184K
45.36%-1.18M
-2.51%427K
-298.84%-857K
118.12%650K
-49.32%222K
-258.77%-2.17M
-Change in payables and accrued expense
-1,630.30%-1.52M
75.21%1.89M
288.18%2.91M
-640.82%-2.65M
52.59%1.53M
-91.28%99K
78.09%1.08M
-10,220.00%-1.55M
54.09%490K
181.43%1M
Cash from discontinued investing activities
Operating cash flow
-11.63%-6.72M
12.80%-24.1M
25.48%-5.41M
0.34%-7.55M
35.93%-5.13M
-25.22%-6.02M
-45.84%-27.64M
-70.41%-7.26M
-76.70%-7.58M
-17.99%-8M
Investing cash flow
Cash flow from continuing investing activities
-85.07%-124K
-81K
-28K
-252.63%-67K
0
0
-61K
Net PPE purchase and sale
----
-85.07%-124K
---81K
---28K
----
----
-252.63%-67K
--0
--0
---61K
Cash from discontinued investing activities
Investing cash flow
----
-85.07%-124K
---81K
---28K
----
----
-252.63%-67K
--0
--0
---61K
Financing cash flow
Cash flow from continuing financing activities
0
20,321.74%4.65M
4.47M
63.64%-4K
508.33%49K
141K
-100.03%-23K
0
54.17%-11K
-12K
Net common stock issuance
--0
--4.17M
--3.96M
--0
--70K
--141K
--0
--0
--0
--0
Net other financing activities
----
2,208.70%485K
--510K
63.64%-4K
----
----
0.00%-23K
--0
---11K
----
Cash from discontinued financing activities
Financing cash flow
--0
20,321.74%4.65M
--4.47M
63.64%-4K
508.33%49K
--141K
-100.03%-23K
--0
54.17%-11K
---12K
Net cash flow
Beginning cash position
-45.42%23.55M
-39.15%43.15M
-51.22%24.58M
-44.53%32.17M
-43.63%37.27M
-39.15%43.15M
367.30%70.9M
-32.97%50.39M
-27.05%58M
-23.40%66.1M
Current changes in cash
-14.31%-6.72M
29.41%-19.57M
85.90%-1.02M
0.07%-7.58M
36.93%-5.09M
-22.14%-5.88M
-149.73%-27.73M
-69.65%-7.26M
-75.97%-7.59M
-19.07%-8.07M
Effect of exchange rate changes
-125.00%-9K
27.59%-21K
-166.67%-6K
47.37%-10K
96.77%-1K
-133.33%-4K
-20.83%-29K
350.00%9K
-18.75%-19K
-416.67%-31K
End cash Position
-54.85%16.82M
-45.42%23.55M
-45.42%23.55M
-51.22%24.58M
-44.53%32.17M
-43.63%37.27M
-39.15%43.15M
-39.15%43.15M
-32.97%50.39M
-27.05%58M
Free cash flow
-11.63%-6.72M
12.56%-24.23M
24.37%-5.49M
-0.03%-7.58M
36.23%-5.14M
-25.07%-6.02M
-46.05%-27.71M
-69.65%-7.26M
-76.70%-7.58M
-18.89%-8.06M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -11.63%-6.72M12.80%-24.1M25.48%-5.41M0.34%-7.55M35.93%-5.13M-25.22%-6.02M-45.84%-27.64M-70.41%-7.26M-76.70%-7.58M-17.99%-8M
Net income from continuing operations 37.21%-4.97M-2.56%-29.77M-51.68%-10.27M34.86%-5.61M11.82%-5.98M-15.26%-7.92M-82.62%-29.03M-139.65%-6.77M-96.60%-8.61M-59.68%-6.78M
Operating gains losses -3,630.77%-1.46M178.20%1.04M841.72%1.12M99.76%-1K94.03%-36K75.63%-39K80.16%-1.34M93.43%-151K74.91%-421K48.59%-603K
Depreciation and amortization 6.67%32K-2.31%127K9.38%35K-3.13%31K-8.82%31K-6.25%30K-20.73%130K-5.88%32K-23.81%32K-22.73%34K
Other non cash items -87.76%108K868.48%891K450.00%14K-91.67%1K0.00%-6K880.00%882K-4.17%92K33.33%-4K271.43%12K-50.00%-6K
Change In working capital -275.86%-925K624.11%1.62M457.91%3.21M-446.35%-2.47M129.92%348K-66.56%526K-78.42%224K-417.31%-898K-5.82%712K36.69%-1.16M
-Change in prepaid assets 38.17%590K68.26%-272K-53.69%301K-17.12%184K45.36%-1.18M-2.51%427K-298.84%-857K118.12%650K-49.32%222K-258.77%-2.17M
-Change in payables and accrued expense -1,630.30%-1.52M75.21%1.89M288.18%2.91M-640.82%-2.65M52.59%1.53M-91.28%99K78.09%1.08M-10,220.00%-1.55M54.09%490K181.43%1M
Cash from discontinued investing activities
Operating cash flow -11.63%-6.72M12.80%-24.1M25.48%-5.41M0.34%-7.55M35.93%-5.13M-25.22%-6.02M-45.84%-27.64M-70.41%-7.26M-76.70%-7.58M-17.99%-8M
Investing cash flow
Cash flow from continuing investing activities -85.07%-124K-81K-28K-252.63%-67K00-61K
Net PPE purchase and sale -----85.07%-124K---81K---28K---------252.63%-67K--0--0---61K
Cash from discontinued investing activities
Investing cash flow -----85.07%-124K---81K---28K---------252.63%-67K--0--0---61K
Financing cash flow
Cash flow from continuing financing activities 020,321.74%4.65M4.47M63.64%-4K508.33%49K141K-100.03%-23K054.17%-11K-12K
Net common stock issuance --0--4.17M--3.96M--0--70K--141K--0--0--0--0
Net other financing activities ----2,208.70%485K--510K63.64%-4K--------0.00%-23K--0---11K----
Cash from discontinued financing activities
Financing cash flow --020,321.74%4.65M--4.47M63.64%-4K508.33%49K--141K-100.03%-23K--054.17%-11K---12K
Net cash flow
Beginning cash position -45.42%23.55M-39.15%43.15M-51.22%24.58M-44.53%32.17M-43.63%37.27M-39.15%43.15M367.30%70.9M-32.97%50.39M-27.05%58M-23.40%66.1M
Current changes in cash -14.31%-6.72M29.41%-19.57M85.90%-1.02M0.07%-7.58M36.93%-5.09M-22.14%-5.88M-149.73%-27.73M-69.65%-7.26M-75.97%-7.59M-19.07%-8.07M
Effect of exchange rate changes -125.00%-9K27.59%-21K-166.67%-6K47.37%-10K96.77%-1K-133.33%-4K-20.83%-29K350.00%9K-18.75%-19K-416.67%-31K
End cash Position -54.85%16.82M-45.42%23.55M-45.42%23.55M-51.22%24.58M-44.53%32.17M-43.63%37.27M-39.15%43.15M-39.15%43.15M-32.97%50.39M-27.05%58M
Free cash flow -11.63%-6.72M12.56%-24.23M24.37%-5.49M-0.03%-7.58M36.23%-5.14M-25.07%-6.02M-46.05%-27.71M-69.65%-7.26M-76.70%-7.58M-18.89%-8.06M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg